GO
Loading...

Enter multiple symbols separated by commas

GlaxoSmithKline PLC

More

  • CHICAGO/ NEW YORK, May 22- As a virulent avian influenza outbreak continues to spread across the Midwestern United States, some egg-dependent companies are contemplating drastic steps- importing eggs from overseas or looking to egg alternatives. A spokeswoman for Archer Daniels Midland Co said that as egg supplies tighten and prices rise, the food processing...

  • CHICAGO and NEW YORK, May 22- As a virulent avian influenza outbreak continues to spread across the Midwestern United States, some egg-dependent companies are contemplating drastic steps: importing eggs from overseas or looking to egg alternatives. "Canada is short on eggs and has been buying heavily from the U.S. for the last several years," said Rick Brown, a...

  • May 20- U.S. healthcare conglomerate Johnson& Johnson said on Wednesday it expects to submit more than 10 new medicines with annual revenue potential of at least $1 billion each to regulators by 2019, and is testing dozens of new uses for existing medicines. J&J said it would file for approval of daratumumab for the blood cancer multiple myeloma in the United...

  • NEW YORK, May 20- U.S. healthcare conglomerate Johnson& Johnson said on Wednesday it expects to submit more than 10 new medicines with annual revenue potential of at least $1 billion each to regulators by 2019, and is testing dozens of new uses for existing medicines. J&J said it would file for approval of the experimental drug daratumumab for the blood cancer...

  • *Tax officials say warned Finance Ministry since September. *Row with investors caused sell-off in India stocks, bonds. MUMBAI, May 19- India's Finance Ministry could have sidestepped a damaging multibillion-dollar tax row with foreign investors if it had acted on regular warning letters that officials had been sending since as long ago as September.

  • Pernix shares jump on migraine drug approval Friday, 15 May 2015 | 1:03 PM ET

    NEW YORK— Shares of Pernix Therapeutics Holdings Inc. jumped Friday after the Food and Drug Administration expanded approval of the migraine drug Treximet. Treximet has been approved for adults since 2008. Pernix acquired U.S. rights to the drug in 2014 from GlaxoSmithKline. Morristown, New Jersey- based Pernix reported just under $21 million in Treximet...

  • *FTSE 100 down 0.1 pct, in line with Europe. LONDON, May 14- Britain's blue-chip FTSE 100 index edged down on Thursday- broadly in line with European shares, hit by a persistent bond-market sell-off- after a mixed bag of corporate earnings and weaker commodity prices. "U.S. and UK stocks appear to be preferred versus German stocks for now, mainly because any increases in...

  • LONDON, May 14- Companies that develop new antibiotics should be awarded prize money of up to $3.5 billion for each new drug, instead of selling the medication at a profit, a review backed by Britain's government said on Thursday. The review, lead by former Goldman Sachs chief economist Jim O'Neill, said the lump sum payments could add up to $16- $37 billion over 10...

  • LONDON, May 11- Britain's GlaxoSmithKline, which decided last week to retain rather than float off its HIV drugs business, is to collaborate with U.S. scientists in developing a cure for AIDS. GSK is tapping into the latest expertise by creating an HIV Cure centre with the University of North Carolina at Chapel Hill and establishing a new jointly owned company.

  • LONDON, May 7- GlaxoSmithKline's new chairman Philip Hampton has thrown his support behind the company's current structure and chief executive despite pressure from some shareholders for a change. Yet Hampton, also chairman of the Royal Bank of Scotland, said there is an issue about GSK's relative performance in terms of shareholder returns.

  • *Labor's Miliband: "We can change Britain". LONDON, May 7- Britons voted on Thursday in the tightest election for decades; one that could cause government gridlock, push the world's fifth-largest economy closer to leaving the European Union and stoke a second attempt by Scotland to break away. Final opinion polls showed Prime Minister David Cameron's...

  • *GlaxoSmithKline boss: we want clarity ASAP. LONDON, May 7- Britons voted on Thursday in the tightest election for decades; one that could cause government gridlock, push the world's fifth-largest economy closer to leaving the European Union and stoke a second attempt by Scotland to break away. Final opinion polls showed Prime Minister David Cameron's...

  • *GlaxoSmithKline boss: we want clarity ASAP. LONDON, May 7- Britons went to vote on Thursday in the tightest election for decades; one that could cause government gridlock, push the world's fifth-largest economy closer to leaving the European Union and stoke a second attempt by Scotland to break away. Final opinion polls showed Prime Minister David Cameron's...

  • *GlaxoSmithKline boss: we want clarity ASAP. LONDON, May 7- Britons began voting on Thursday in a tight election that could yield a weak government, push the world's fifth-largest economy a step closer to leaving the European Union and stoke Scottish desires for secession. Final opinion polls showed Prime Minister David Cameron's Conservatives and Ed...

  • WASHINGTON, May 6- The U.S. Food and Drug Administration will hold a public meeting this summer to address drug company concern that restrictions on what they can say about off-label use of drugs violate their first amendment right to free speech. Efforts by drug companies to change the rules gained steam after a 2012 decision from the Second Circuit Court of...

  • *GlaxoSmithKline boss: we want clarity ASAP. LONDON, May 7- British voters get to decide on Thursday who they want to rule the world's fifth-largest economy in a tight election that could yield weak government, propel the United Kingdom towards a vote on EU membership and stoke Scottish desire for secession. Prime Minister David Cameron's Conservatives and Ed...

  • GSK CEO: Why we're betting on drug volume, not price Wednesday, 6 May 2015 | 12:21 PM ET

    GlaxoSmithKline laid out growth targets for biggest businesses on Wednesday, hoping to convince investors that it would return to long-term growth.

  • Europe shares end mostly higher as euro rallies Wednesday, 6 May 2015 | 11:30 AM ET
    Earnings report

    European equities closed mostly higher on Wednesday as investors reacted to a slew of earnings reports and data, as the euro rallied against the dollar.

  • It also scaled back plans to return 4 billion pounds of cash flowing from a $20 billion- plus asset swap with Novartis to investors, opting instead to pay a 1 billion special dividend. Chief Executive Andrew Witty is under pressure to demonstrate that the Novartis deal can revive GSK's fortunes by focusing it on consumer health and vaccines, following a slide in...

  • Wall Street eyes rebound amid data and spiking yields Wednesday, 6 May 2015 | 8:59 AM ET
    A trader works on the floor of the New York Stock Exchange.

    U.S. stock futures pointed to a firm open, following the previous day's sharp falls and amid key data releases as yields held near recent highs.